Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist

Fertil Steril. 2006 Feb;85(2):412-9. doi: 10.1016/j.fertnstert.2005.08.020.

Abstract

Objective: To compare levels of apoptosis in granulosa cells from women treated with the gonadotropin-releasing hormone (GnRH) agonist triptorelin or the GnRH antagonist cetrorelix.

Design: Randomized, prospective study.

Setting: University hospital.

Patient(s): Thirty-two women undergoing assisted reproduction techniques after ovulation induction with recombinant follicle-stimulating hormone (FSH) plus GnRH agonist or antagonist.

Intervention(s): Granulosa cells were isolated from follicular aspirates after oocyte removal.

Main outcome measure(s): Apoptosis was assessed with Annexin V binding assay, terminal deoxynucleotidyl transferase (TdT)-mediated nick-end labeling (TUNEL) assay, flow cytometric analysis of DNA, and ultrastructural analysis of cell morphology in transmission electron microscopy. Serum and follicular hormonal levels were also determined.

Result(s): Annexin V binding and TUNEL assays revealed comparable percentages of apoptosis in the two groups under investigation. Analysis of DNA histograms revealed a similar cell cycle distribution in the two groups. Ultrastructural analysis only occasionally displayed patterns of chromatin margination in apoptotic cells. The mean concentrations of all the follicular fluid steroid hormones evaluated (E2, T, and P) were significantly lower in the GnRH antagonist-treated group.

Conclusion(s): Therapy with a GnRH agonist or antagonist is associated with comparable levels of apoptosis in granulosa cells.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Annexin A5 / metabolism
  • Apoptosis / drug effects*
  • Cell Cycle
  • Chromatin / ultrastructure
  • DNA
  • Estradiol / analysis
  • Female
  • Follicle Stimulating Hormone / therapeutic use
  • Follicular Fluid / chemistry
  • Gonadotropin-Releasing Hormone / agonists*
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors*
  • Gonadotropin-Releasing Hormone / therapeutic use
  • Granulosa Cells* / metabolism
  • Granulosa Cells* / ultrastructure
  • Hormone Antagonists / therapeutic use*
  • Humans
  • In Situ Nick-End Labeling
  • Microscopy, Electron
  • Ovulation Induction
  • Progesterone / analysis
  • Recombinant Proteins / therapeutic use
  • Reproductive Techniques, Assisted
  • Testosterone / analysis
  • Triptorelin Pamoate / therapeutic use*

Substances

  • Annexin A5
  • Chromatin
  • Hormone Antagonists
  • Recombinant Proteins
  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Progesterone
  • Estradiol
  • Follicle Stimulating Hormone
  • DNA
  • cetrorelix